Katja Repnik

Genetic Polymorphism in <i>ATG16L1</i> Gene Influences the Response to Adalimumab in Crohn’s Disease Patients

Silvo Koder, Katja Repnik, Ivan Ferkolj et al. · Pharmacogenomics · 2015 · 63 citations

Carboxymethyl cellulose/diclofenac bioactive coatings on AISI 316LVM for controlled drug delivery, and improved osteogenic potential

Uroš Maver, Klodian Xhanari, Marko Žižek et al. · Carbohydrate Polymers · 2019 · 48 citations

Tissue Engineering, Engineering, Aisi 316Lvm +5

<i>CTLA4</i> CT60 Single-Nucleotide Polymorphism Is Associated with Slovenian Inflammatory Bowel Disease Patients and Regulates Expression of <i>CTLA4</i> Isoforms

Katja Repnik, Uroš Potočnik · DNA and Cell Biology · 2010 · 32 citations

A Prospective Pharmacogenomic Study of Crohn's Disease Patients during Routine Therapy with Anti-TNF-α Drug Adalimumab: Contribution of <i>ATG5</i> , <i>NFKB1,</i> and <i>CRP</i> Genes to Pharmacodynamic Variability

Matjaž Deželak, Katja Repnik, Silvo Koder et al. · OMICS A Journal of Integrative Biology · 2016 · 26 citations

Downregulation of ABCB1 gene in patients with total hip or knee arthroplasty influences pharmacokinetics of rivaroxaban: a population pharmacokinetic-pharmacodynamic study

Jurij Zdovc, Maja Petre, Mitja Pišlar et al. · European Journal of Clinical Pharmacology · 2019 · 24 citations

Medicine, Abcb1 Gene, Clinical Pharmacology +5